ICM
KITE

IronBridge Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

IronBridge Capital Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$4.14M Buy
52,800
+5,670
+12% +$351K 0.25% 128
2016
Q4 		$2.11M Buy
+47,130
New +$2.31M 0.09% 145

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

IronBridge Capital Management's KITE Position: Q1 2017 in Review

IronBridge Capital Management increased its Kite Pharma, Inc. (KITE) stake by 12% in Q1 2017, buying an estimated $351K and bringing the position to 52,800 shares worth $4.14M. The position accounts for 0.25% of the portfolio, ranked #128.

IronBridge Capital Management first reported a position in KITE in Q4 2016 and has held it in 2 quarters since. 209 funds tracked by Wall St. Rank hold KITE as of Q1 2017.

  • IronBridge Capital Management held 52,800 shares of Kite Pharma, Inc. worth $4.14M as of Q1 2017.
  • IronBridge Capital Management bought 5,670 Kite Pharma, Inc. shares in Q1 2017, an estimated $351K.
  • Kite Pharma, Inc. made up 0.25% of IronBridge Capital Management's portfolio in Q1 2017, its #128 holding.
  • IronBridge Capital Management first reported a position in Kite Pharma, Inc. in Q4 2016 and has held it in 2 quarters since.
  • 209 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2017.

Based on IronBridge Capital Management's 13F filing for Q1 2017, filed 10 May 2017.